Figure 1.
Prevalence of (a) curable sexually transmitted infections, and (b) syndromes diagnosed, by visit month, in a cohort of women at increased risk for HIV acquisition in northwestern Tanzania.
Lighter shaded section of each bar represents those who were diagnosed by syndromic management. Values shown at the top of the bars are the overall prevalence (%). CT = Chlamydia trachomatis, NG = Neisseria gonorrhoeae, TV = Trichomonas vaginalis, syph = high-titre active syphilis.
Table 1.
Trend in prevalence of laboratory-diagnosed curable sexually transmitted infections and syndromes diagnosed over the 12 month follow-up period in a cohort of women at increased risk for HIV acquisition in northwestern Tanzania.
Figure 2.
Prevalence of syndromes diagnosed, by visit month, in a cohort of women at increased risk for HIV acquisition in northwestern Tanzania.
Values shown at the top of the bars are the prevalence (%). PID = pelvic inflammatory disease, VDS = vaginal discharge syndrome.
Table 2.
Performance of syndromes for detection of laboratory-diagnosed sexually transmitted infections (STI) and bacterial vaginosis over the 12 month follow-up period in a cohort of women at increased risk for HIV acquisition in northwestern Tanzania.
Table 3.
Associations of C. trachomatis, N. gonorrhoeae, T. vaginalis and active syphilis (high-titre) with sociodemographic, behavioural and biological factors in a cohort of women at increased risk for HIV acquisition in northwestern Tanzania.